Table 1. Patient Characteristics.

	All Patients ( N =325)
Characteristics	No.	%
	Age classes
<18	3	0.92
18–35	71	21.85
36–39	51	15.69
40–49	103	31.69
50–59	61	18.77
60–69	31	9.54
≥70	5	1.54
	Sex
Male	203	62.46
Female	122	37.54
	WHO grade classes
Grade II	109	33.54
Grade III	72	22.15
Grade IV	144	44.31
	TCGA classes
Classical	74	22.77
Mesenchymal	68	20.92
Neural	81	24.92
Proneural	102	31.39
	Chemoradiotherapy
Radiotherapy plus other drugs	8	2.46
Radiotherapy plus temozolomide	78	24.00
Radiotherapy plus unknown drug	64	19.69
Chemotherapy with temozolomide alone	12	3.69
Chemotherapy with unknown drug alone	14	4.31
Radiotherapy alone	87	26.77
No data for radiotherapy plus temozolomide	1	0.31
Radiotherapy plus no data for chemotherapy	2	0.62
No data for chemoradiotherapy	27	8.31
No therapy	32	9.84
	Epilepsy therapy
Anti-epileptic	85	26.15
No therapy	157	48.31
No data	83	25.54